Investors Bancorp Stock Forecast, Price & News

Investors Bancorp (NASDAQ:ISBC) Frequently Asked Questions

Is Investors Bancorp a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Investors Bancorp in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Investors Bancorp stock.
View analyst ratings for Investors Bancorp or view top-rated stocks.

How has Investors Bancorp's stock price been impacted by Coronavirus (COVID-19)?

Investors Bancorp's stock was trading at $9.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ISBC stock has increased by 63.2% and is now trading at $15.42.
View which stocks have been most impacted by COVID-19.

When is Investors Bancorp's next earnings date?

Investors Bancorp is scheduled to release its next quarterly earnings announcement on Wednesday, January 26th 2022.
View our earnings forecast for Investors Bancorp.

How were Investors Bancorp's earnings last quarter?

Investors Bancorp, Inc. (NASDAQ:ISBC) posted its quarterly earnings results on Tuesday, October, 26th. The savings and loans company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.31 by $0.03. The savings and loans company had revenue of $210.55 million for the quarter, compared to analysts' expectations of $211.83 million. Investors Bancorp had a net margin of 28.94% and a trailing twelve-month return on equity of 11.23%. The company's revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.27 earnings per share.
View Investors Bancorp's earnings history.

How often does Investors Bancorp pay dividends? What is the dividend yield for Investors Bancorp?

Investors Bancorp declared a quarterly dividend on Wednesday, October 27th. Stockholders of record on Wednesday, November 10th will be paid a dividend of $0.14 per share on Friday, November 26th. This represents a $0.56 annualized dividend and a dividend yield of 3.63%. The ex-dividend date is Tuesday, November 9th.
View Investors Bancorp's dividend history.

Is Investors Bancorp a good dividend stock?

Investors Bancorp pays an annual dividend of $0.56 per share and currently has a dividend yield of 3.48%. Investors Bancorp has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Investors Bancorp is 44.80%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Investors Bancorp will have a dividend payout ratio of 43.08% next year. This indicates that Investors Bancorp will be able to sustain or increase its dividend.
View Investors Bancorp's dividend history.

What price target have analysts set for ISBC?

5 Wall Street analysts have issued 12-month price objectives for Investors Bancorp's stock. Their forecasts range from $14.50 to $18.00. On average, they expect Investors Bancorp's stock price to reach $16.40 in the next twelve months. This suggests a possible upside of 6.4% from the stock's current price.
View analysts' price targets for Investors Bancorp or view top-rated stocks among Wall Street analysts.

Who are Investors Bancorp's key executives?

Investors Bancorp's management team includes the following people:

• Kevin Cummings, Chairman & Chief Executive Officer
• Domenick A. Cama, President, Chief Operating Officer & Director
• P. Sean Burke, Chief Financial Officer & Executive Vice President
• Richard S. Spengler, Chief Lending Officer & Executive Vice President
• Brian F. Doran, Secretary, Executive VP & General Counsel

What is Kevin Cummings' approval rating as Investors Bancorp's CEO?

92 employees have rated Investors Bancorp CEO Kevin Cummings on Glassdoor.com. Kevin Cummings has an approval rating of 58% among Investors Bancorp's employees. This puts Kevin Cummings in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Investors Bancorp's key competitors?

Some companies that are related to Investors Bancorp include The PNC Financial Services Group (PNC), Truist Financial (TFC), SVB Financial Group (SIVB), First Republic Bank (FRC), Fifth Third Bancorp (FITB), Regions Financial (RF), Huntington Bancshares (HBAN), KeyCorp (KEY), M&T Bank (MTB), Signature Bank (SBNY), Western Alliance Bancorporation (WAL), East West Bancorp (EWBC), Zions Bancorporation, National Association (ZION), First Horizon (FHN) and Cullen/Frost Bankers (CFR).
View all of ISBC's competitors.

What other stocks do shareholders of Investors Bancorp own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Investors Bancorp investors own include Chembio Diagnostics (CEMI), PIMCO High Income Fund (PHK), Pernix Therapeutics (PTX), Two Harbors Investment (TWO), KeyCorp (KEY), Prospect Capital (PSEC), Bank of America (BAC), Walt Disney (DIS), Ford Motor (F) and Johnson & Johnson (JNJ).

What is Investors Bancorp's stock symbol?

Investors Bancorp trades on the NASDAQ under the ticker symbol "ISBC."

Who are Investors Bancorp's major shareholders?

Investors Bancorp's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.11%), Fuller & Thaler Asset Management Inc. (6.68%), Dimensional Fund Advisors LP (4.83%), Geode Capital Management LLC (1.53%), CNH Partners LLC (1.43%) and Bank of New York Mellon Corp (1.23%). Company insiders that own Investors Bancorp stock include James J Garibaldi, John E Sr Harmon Sr and P Sean Burke.
View institutional ownership trends for Investors Bancorp.

Which institutional investors are selling Investors Bancorp stock?

ISBC stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Victory Capital Management Inc., BlackRock Inc., KBC Group NV, Deutsche Bank AG, Geode Capital Management LLC, Balyasny Asset Management LLC, and Mutual of America Capital Management LLC.
View insider buying and selling activity for Investors Bancorp or view top insider-selling stocks.

Which institutional investors are buying Investors Bancorp stock?

ISBC stock was bought by a variety of institutional investors in the last quarter, including CNH Partners LLC, Arrowstreet Capital Limited Partnership, Wellington Management Group LLP, Millennium Management LLC, Goldman Sachs Group Inc., Alliancebernstein L.P., Citigroup Inc., and Nordea Investment Management AB.
View insider buying and selling activity for Investors Bancorp or or view top insider-buying stocks.

How do I buy shares of Investors Bancorp?

Shares of ISBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Investors Bancorp's stock price today?

One share of ISBC stock can currently be purchased for approximately $15.42.

How much money does Investors Bancorp make?

Investors Bancorp has a market capitalization of $3.82 billion and generates $1.07 billion in revenue each year. The savings and loans company earns $221.58 million in net income (profit) each year or $1.25 on an earnings per share basis.

How many employees does Investors Bancorp have?

Investors Bancorp employs 1,874 workers across the globe.

When was Investors Bancorp founded?

Investors Bancorp was founded in 1926.

What is Investors Bancorp's official website?

The official website for Investors Bancorp is www.myinvestorsbank.com.

Where are Investors Bancorp's headquarters?

Investors Bancorp is headquartered at 101 JFK PARKWAY, SHORT HILLS NJ, 07078.

How can I contact Investors Bancorp?

Investors Bancorp's mailing address is 101 JFK PARKWAY, SHORT HILLS NJ, 07078. The savings and loans company can be reached via phone at (973) 924-5100, via email at [email protected], or via fax at 973-924-5192.